Dose-finding and safety study of a new Shigella vaccine combined with an adjuvant in the Netherlands and Zambia

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506394-35-02

Acronym

SUNSHINE

Enrollment

Registered

2024-07-02

Start date

2024-09-12

Completion date

2025-09-26

Last updated

2024-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination against shigellosis (in healthy adults)

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026